Edwards Lifesciences halts enrollment in a clinical trial of its Fortis mitral valve implant after some patients developed blood clots in the devices.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1Fm3KjG
Cap comentari:
Publica un comentari a l'entrada